Related Experiment Video
Updated: May 8, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Pediatric heart failure and transplantation: where are we in 2013?
1Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, USA.
Insights
Recent advancements in pediatric heart transplantation offer excellent long-term survival, particularly for infants. However, challenges arise from increased referrals due to failed congenital heart surgeries, necessitating earlier transplant evaluations.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Transplantation Medicine
Background:
- Chronic medical management of pediatric heart failure shows limited progress.
- Disparities in molecular regulation (e.g., β2-adrenergic receptors, microRNA) exist between pediatric and adult heart failure.
- Pediatric ventricular assist devices improve bridge-to-transplant survival but are limited for destination therapy.
Purpose of the Study:
- To review recent publications on pediatric heart failure.
- To analyze recent developments in pediatric heart transplantation.
Main Methods:
- Literature review of recent publications.
- Analysis of current trends and challenges in pediatric heart failure and transplantation.
Main Results:
- Significant developments in pediatric heart transplantation include understanding antibody-mediated graft dysfunction, ABO-incompatible transplants, adjusted pulmonary vascular resistance limits, and outcome prediction.
- Failed single-ventricle palliation is an increasing reason for pediatric heart transplantation, posing unique challenges.
- Pediatric heart transplantation demonstrates excellent long-term survival, often exceeding 20 years, especially in infants.
Conclusions:
- Despite excellent outcomes, a growing number of pediatric patients referred after failed congenital heart surgery, particularly single-ventricle palliation, present new obstacles that may impact survival rates.
- Earlier referral for transplant evaluation may help mitigate these challenges and maintain favorable outcomes in pediatric heart transplantation.
Purpose Of Review:
To review the recent publications on pediatric heart failure and pediatric transplantation.
Recent Findings:
Little progress has been made in the chronic medical management of pediatric heart failure. Basic science studies demonstrating disparate regulation of β2-adrenergic receptors and microRNA between pediatric and adult heart failure may give clues to the lack of improvement in pediatric outcomes. Pediatric ventricular assist devices have significantly improved survival of bridge-to-transplant, but currently have too many limitations for destination therapy for children. Several areas of pediatric heart transplant have had significant developments over the last few years: the role of antibodies in mediating graft dysfunction after transplantation, ABO-incompatible transplant, extending the pediatric limits on acceptable pulmonary vascular resistance, and risk prediction of pediatric transplant outcomes. Failed single-ventricle palliation is a growing indication for heart transplantation with its own unique challenges.
Summary:
Pediatric heart transplantation can have excellent outcomes with survival beyond 20 years after transplant common, especially in the infant. However, the growing population of children and young adults being referred for heart transplantation after failed congenital heart surgery, especially after failed single-ventricle palliation, is presenting new obstacles that may start reducing the survival rates for pediatric heart transplantation. This may in part be ameliorated by earlier referral for transplant evaluation.
Related Concept Videos
Kidney Transplant I: Introduction
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management

